NCT05937529View on ClinicalTrials.gov

Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Actinic Keratoses
Interventions
OTHER

Cream containing madecassoside and 5 % panthenol

Immediately after daylight PDT, Cicaplast is administrated as post treatment. The patients are instructed to apply the cream twice daily for 14 days.

OTHER

Daylight PDT

Daylight PDT performed with 2 hours of artifical indoor light.

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen NV

All Listed Sponsors
collaborator

L'Oreal

INDUSTRY

lead

Merete Haedersdal

OTHER

NCT05937529 - Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis | Biotech Hunter | Biotech Hunter